InsidersTradesSigma
Discover the detailed record of transactions filed by Callos Andrew, Directeur Commercial. Insider active across 1 companies, notably CYTOKINETICS INC. In total, 2 disclosures have been logged. The latest transaction was filed on 2 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Callos Andrew is Executive Vice President and Chief Commercial Officer at Cytokinetics Inc. He oversees the company's commercial and sales strategies, aiming to maximize revenue and strengthen market position. His experience in business development is a significant asset for the company's expansion.